Alexander Pertsemlidis

Prof. Alexander Pertsemlidis

Greehey Children’s Cancer Research Institute
+2
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2008 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SRStefano Romeo
Stefano Romeo
JKJulia Kozlitina
Julia Kozlitina
CXChao Xing
Chao Xing
Alexander PertsemlidisAlexander Pertsemlidis
Alexander Pertsemlidis
DCDavid Cox
David Cox
HHHelen H Hobbs
Helen H Hobbs
Helen Hobbs and colleagues report an association between coding variation in PNPLA3 and susceptibility to nonalcoholic fatty liver disease. The associated alleles vary in frequency among Hispanics, African Americans and European Americans and contribute to differences in disease prevalence among these ancestry groups. Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology that varies in prevalence among ancestry groups. To identify genetic variants contributing to differences in hepatic fat content, we carried out a genome-wide association scan of nonsynonymous sequence variations (n = 9,229) in a population comprising Hispanic, African American and European American individuals. An allele in PNPLA3 (rs738409[G], encoding I148M) was strongly associated with increased hepatic fat levels (P = 5.9 × 10−10) and with hepatic inflammation (P = 3.7 × 10−4). The allele was most common in Hispanics, the group most susceptible to NAFLD; hepatic fat content was more than twofold higher in PNPLA3 rs738409[G] homozygotes than in noncarriers. Resequencing revealed another allele of PNPLA3 (rs6006460[T], encoding S453I) that was associated with lower hepatic fat content in African Americans, the group at lowest risk of NAFLD. Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.

8 June 2007 in Science
Verified
Journal Article
Closed access
PDF file
RMRuth McPherson
Ruth McPherson
Alexander PertsemlidisAlexander Pertsemlidis
Alexander Pertsemlidis
NKNihan Kavaslar
Nihan Kavaslar
ASAlexandre Stewart
Alexandre Stewart
RRRobert Roberts
Robert Roberts
JCJonathan C. Cohen
Jonathan C. Cohen
Coronary heart disease (CHD) is a major cause of death in Western countries. We used genome-wide association scanning to identify a 58-kilobase interval on chromosome 9p21 that was consistently associated with CHD in six independent samples (more than 23,000 participants) from four Caucasian populations. This interval, which is located near the CDKN2A and CDKN2B genes, contains no annotated genes and is not associated with established CHD risk factors such as plasma lipoproteins, hypertension, or diabetes. Homozygotes for the risk allele make up 20 to 25% of Caucasians and have a ∼30 to 40% increased risk of CHD.

16 January 2005 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JCJonathan Cohen
Jonathan Cohen
Alexander PertsemlidisAlexander Pertsemlidis
Alexander Pertsemlidis
IKIngrid K Kotowski
Ingrid K Kotowski
RGRandall Graham
Randall Graham
CGChristine Kim Garcia
Christine Kim Garcia
HHHelen H Hobbs
Helen H Hobbs

6 August 2004 in Science
Verified
Journal Article
Closed access
PDF file
JCJonathan C. Cohen
Jonathan C. Cohen
RKRobert S. Kiss
Robert S. Kiss
Alexander PertsemlidisAlexander Pertsemlidis
Alexander Pertsemlidis
YMYves L. Marcel
Yves L. Marcel
RMRuth McPherson
Ruth McPherson
HHHelen H. Hobbs
Helen H. Hobbs
Heritable variation in complex traits is generally considered to be conferred by common DNA sequence polymorphisms. We tested whether rare DNA sequence variants collectively contribute to variation in plasma levels of highdensity lipoprotein cholesterol (HDL-C). We sequenced three candidate genes ( ABCA1, APOA1 , and LCAT ) that cause Mendelian forms of low HDL-C levels in individuals from a population-based study. Nonsynonymous sequence variants were significantly more common (16% versus 2%) in individuals with low HDL-C (95th percentile). Similar findings were obtained in an independent population, and biochemical studies indicated that most sequence variants in the low HDL-C group were functionally important. Thus, rare alleles with major phenotypic effects contribute significantly to low plasma HDL-C levels in the general population.

1 March 2006 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
IKIngrid K. Kotowski
Ingrid K. Kotowski
Alexander PertsemlidisAlexander Pertsemlidis
Alexander Pertsemlidis
ALAmy Luke
Amy Luke
RCRichard S. Cooper
Richard S. Cooper
GVGloria L. Vega
Gloria L. Vega
HHHelen H. Hobbs
Helen H. Hobbs

15 September 2009 in Genes & Development
Verified
Journal Article
Closed access
PDF file
DGDon L. Gibbons
Don L. Gibbons
WLWei Lin
Wei Lin
CCChad J. Creighton
Chad J. Creighton
ZRZain H. Rizvi
Zain H. Rizvi
Philip GregoryPhilip Gregory
Philip Gregory
JKJonathan M. Kurie
Jonathan M. Kurie
Metastatic disease is a primary cause of cancer-related death, and factors governing tumor cell metastasis have not been fully elucidated. Here, we address this question by using tumor cell lines derived from mice that develop metastatic lung adenocarcinoma owing to expression of mutant K-ras and p53. Despite having widespread somatic genetic alterations, the metastasis-prone tumor cells retained a marked plasticity. They transited reversibly between epithelial and mesenchymal states, forming highly polarized epithelial spheres in three-dimensional culture that underwent epithelial-to-mesenchymal transition (EMT) following treatment with transforming growth factor-β or injection into syngeneic mice. This transition was entirely dependent on the microRNA (miR)-200 family, which decreased during EMT. Forced expression of miR-200 abrogated the capacity of these tumor cells to undergo EMT, invade, and metastasize, and conferred transcriptional features of metastasis-incompetent tumor cells. We conclude that tumor cell metastasis is regulated by miR-200 expression, which changes in response to contextual extracellular cues.